New drug approved which could drastically reduce effects of a heart attack Scotsman PATIENTS with chronic heart failure are to be offered a new drug which reduces their risk of being hospitalised by almost 40 per cent. Inspra (eplerenone) accepted for use within NHS Scotland |
